Finance

Beta
Lists
GRAL:BMV
Grail Inc
MX$825.00
0.00%
(0.00) 1D
Apr 10, 11:51:14 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for GRAL...
Mkt. cap
2.57B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$1,828.00
52-wk low
MX$606.20
No. of employees
910
Mkt. cap
2.57B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$1,828.00
52-wk low
MX$606.20
No. of employees
910
News stories
From sources across the web
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
35.54M
36.19M
43.60M
40.78M
Cost of goods sold
19.85M
16.45M
21.26M
21.62M
Cost of revenue
19.85M
16.45M
21.26M
21.62M
Research and development expenses
46.63M
48.65M
46.90M
48.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
66.45M
62.91M
66.38M
73.44M
Operating expense
146.55M
145.03M
146.75M
154.93M
Total operating expenses
166.40M
161.48M
168.01M
176.55M
Operating income
-130.85M
-125.29M
-124.41M
-135.76M
Other non operating income
-
-
-993.00K
-
EBT including unusual items
-152.86M
-118.72M
-116.52M
-127.52M
EBT excluding unusual items
-124.86M
-118.72M
-116.52M
-127.52M
Income tax expense
-38.87M
-29.74M
-17.34M
-34.34M
Effective tax rate
25.43%
25.05%
14.88%
26.93%
Other operating expenses
-
-
-
-
Net income
-113.98M
-88.98M
-99.18M
-93.19M
Net profit margin
-320.69%
-245.83%
-227.48%
-228.48%
Earnings per share
-3.18
-2.46
-2.44
-1.37
Interest and investment income
6.81M
6.11M
7.96M
7.99M
Interest expense
-
-
-
-
Net interest expenses
6.81M
6.11M
7.96M
7.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
-91.68M
-86.31M
-85.50M
-96.97M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer